Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: J Immunother. 2009 Jul–Aug;32(6):655–666. doi: 10.1097/CJI.0b013e3181a80e0d

FIGURE 4. MHC restriction of PSA3A peptide-specific CD8 T cell response.

FIGURE 4

CD8 T cell line from patient Pr150 was tested in IFN-γ ELISPOT assay against HLA-A2 expressing OVCAR3 tumor cells pulsed with PSA3A peptide in the presence of anti-HLA class I, anti-HLA-DR or isotype control antibodies. The data are mean ±SD of triplicate determinations.